Business Opportunities in Spain's Fast-Growing Biotechnology Industry
MADRID, July 9 /PRNewswire/ --
- INVEST IN SPAIN would like to invite you to take part in an online
seminar entitled "Business Opportunities
in the Biotechnology, Pharma and
Life Sciences Sector", in which business opportunities
will be presented for
foreign companies in the sector in S...
Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
China, India, Israel, many more to attend global event for health care leaders in businesses, government, April 14-16, 2009, Washington , D.C.
WASHINGTON, March 31 /PRNewswire/ -- The 6th Annual World Health Care Congress, April 14-16, Washington, D.C., is pleased to announce sev...
RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference
BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opp...
PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma
PharmSource Lead Sheet upgrades database resources to help companies serving biotech/pharma industry to find new business opportunities
and market intelligence.
Springfield, VA (PRWEB) November 24, 2008 -- In response to challenging economic times, PharmSource Informati...
Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
NETTLETON, Miss., Nov. 7 /PRNewswire-FirstCall/ -- Universal Bioenergy,
Inc. (Pink Sheets: UBRG) CEO, Dr. Richard Craven, stated, "Algae can become
a prominent source of energy, and with several new algae technology
companies emerging, it is a good time to form alliances. We have identified
New Opportunities in X-Ray Based Surgical Navigation With Ziehm NaviPort 3D
Ziehm Imaging and BrainLAB Improve Intra-Operative Imaging With Navigation for More Gentle, Less Invasive Surgery
NUREMBERG and MUNICH, Germany, October 6 /PRNewswire/ -- Ziehm Imaging
and BrainLAB have developed the Ziehm NaviPort 3D interface, representing
an important step fo...
U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital
marketplace is multifaceted and can be divided into multiple market
segments. In this challenging marketplace, pharmaceutical and biotechnology
sales people must negotiate increasingly complex organizational and
Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report
SCOTTSDALE, Ariz., Feb. 26 /PRNewswire/ -- MedPredict Market Research,
a global provider of pharmaceutical competitive intelligence and market
research, has published a new report providing critical strategic insight
for pharma and biotech companies with a stake in the market for Rheumatoid
GPhA Annual Meeting Focuses on Industry Opportunities and Challenges for 2008
BOCA RATON, Fla., Feb. 12 /PRNewswire/ -- More than 400 generic
industry leaders, financial experts and political officials gathered today
for the Generic Pharmaceutical Association (GPhA) Annual Meeting to discuss
the critical issues facing the generic industry in 2008. With the theme of
Targanta to Present at 9th Annual Mass Opportunities Investment Conference
Presentation to be Webcast at 11:45 am ET on November 8, 2007
CAMBRIDGE, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Targanta
Therapeutics Corporation (Nasdaq: TARG ) today announced its participation
in the Massachusetts Biotechnology Council's (MBC's) annual MASS
Opportunities Investment C...
2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Ninth Annual Biotechnology Investor Conference, November 8, Features Private and Small to Mid-cap Public Growth Companies Renowned Investment Banker and Biotechnology Company Start-up Leader Stelios Papadopoulos, PhD Provides Keynote Address
BOSTON, Oct. 16 /PRNewswire/ -...
Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
- JDRF President's goal is to progress research from academic settings to clinical trials and marketable drugs and therapeutics -
BOSTON, Oct. 2 /PRNewswire-USNewswire/ -- The promise of research
utilizing adult and embryonic stem cells is broader than most might think,
including not onl...
Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
London, July 20 /PRNewswire/ -- There has been a recent upsurge in Merger & Acquisition (M&A) activities in the pharmaceutical and biotechnology space. While the economic downturn and related credit crunch has had an impact, this alone cannot account for the recent M&A mania,...
New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
BEDFORD, Mass., July 14 /PRNewswire/ -- RISI, the leading information provider for the global forest products industry, today announced the publication of the South American Tree Farm Update: Opportunities
for Investment in Forest Industry and Biomass Energy Plantations . This new study upda...
Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities
Product and Operational Targets Presented At JPMorgan Healthcare Conference
SAN FRANCISCO, Jan. 12 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced product and operational targets for 2009 that provide the opportunity to transform diabetes and obesity ...
Two Metabolex Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities
HAYWARD, Calif., Nov. 3 /PRNewswire/ -- Metabolex, Inc., a
biopharmaceutical company focused on the discovery and development of
proprietary new medicines for the treatment of metabolic diseases,
announced that two of its programs (MBX-2982 and MBX-8025) have been
recognized in Windhover's "To...
CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
SARASOTA, Fla., Sept. 29 /PRNewswire-FirstCall/ -- CPC of America, Inc.
(OTC Bulletin Board: CPCF.OB) today announced that it had retained FTI
Capital Advisors, LLC, the investment banking subsidiary of FTI Consulting,
Inc., to explore strategic alternatives for the Company.
As CPC of Americ...
Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
WOBURN, Massachusetts, March 17 /PRNewswire/ -- Mercury Therapeutics,
Inc. (MTI), a company that discovers and develops orally active protein
kinase targeted drugs, announces that it has retained Marquant Partners LLC
( http://www.marquantpartners.com ) to advise on its strategic and partnerin...
BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
BIRMINGHAM, Ala., Jan. 10 /PRNewswire-FirstCall/ -- BioCryst
Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced Thomas J. Simon, M.D.
has joined BioCryst as a consultant and interim Chief Medical Officer. Dr.
Simon brings more than 20 years of expertise in global pharmaceutical
SBC merger with AT&T could open opportunities in Wisconsin
After SBC Communications' Monday announcement that it plans to buy its former parent AT&T , rival communications companies are keeping their eyes open for new opportunities.
Drew Petersen, director of legislative affairs for TDS Telecom , said the merger between SBC and AT&T is a sign that S...
British, Wisconsin firms explore life-science opportunities together
Madison, Wis. Representatives of the British Consulate-General, which is looking to expand its bio and health technology investments, met Wisconsin companies on Tuesday for a luncheon to explore opportunities
"We're looking for companies with complimentary products or compl...
RFID medical devices - Opportunities and challenges
June's column on information technology opportunities
noted that the FDA sees radio frequency identification (RFID) technology as critical for the long-term safety and integrity of the U.S. drug supply. RFID allows pharmaceutical packages to be tracked, traced and authenticated throughout the c...
Big opportunities with small businesses
"We are men of action. Lies do not become us."
- Dread Pirate Roberts, The Princess Bride
Small business owners sometime seem like a big challenge to marketers. They can be difficult to target and easily dissuaded. Given the right opportunity, however, small business owners can also be ti...
Challenging times for FDA and drug companies equals IT opportunities
Even before the intense scrutiny that started in September when Vioxxs manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road.
One of the biggest challenges has been the pipeline problem, th...
... and other fields of science."
Says Dahmen, "From a microscopist's point of view, the ability to observe nanoparticles in liquid solution opens new opportunities
in an area that has traditionally been off-limits because electron microscopes require vacuum conditions. We can now see directly what before could on...
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...e continue to work with our investment bankers on potential strategic transactions, including mergers and other business combinations that could yield opportunities
to increase shareholder value and provide additional resources for us to develop our Controlled Delivery Technology (CDT(R)) platforms. However, we ar...
Novavax Reports Second Quarter 2009 Financial Results
...x may pursue additional funding through the potential sale of equity securities, other non-dilutive financing, or additional partnering agreements, as opportunities
Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infe...
Synthetech Reports First Quarter Fiscal 2010 Results
...credit crises on the Company's business and customers; strength of the biopharmaceutical customer base; adequacy of project pipeline to provide market opportunities
and Company performance for the balance of fiscal 2010. Words such as "believe," "anticipate," "expect," "estimate," "project," "will be," "will cont...
Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team
...ed founder & CEO Daniel Napoli's visionary approach to how users interact with supply chain software is innovative and differentiated creating new opportunities
for driving efficiencies and productivity. Knighted is well positioned to enhance their customers' global supply chains for today and the future."
The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.
...s to support the mission of the National Institutes of Health - improving health through scientific discovery. The Foundation identifies and develops opportunities
for innovative public-private partnerships and collaborations and brings together industry, academia, and the philanthropic community in support of th...
Microbia Names John McCarthy to Senior Management Team
...nd development-focused organizations to broad commercial entities will be vital as we accelerate our plans to take advantage of the large-scale market opportunities
afforded by our technologies."
"I'm very pleased to be joining Microbia at this important time in its development," stated Mr. McCa...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
... primary receptor responsible for human salt taste perception. These enhancers represent 12 diverse sample classes and therefore may provide numerous opportunities
for the discovery of a new flavor ingredient that enables a reduction in the use of salt. The enhancers are being optimized and evaluated in taste te...
AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
...d resources to pursue R D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities
in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult t...
Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business
...xpands our geographic reach and scale. We are confident that the combination of Olympus diagnostics with our business will provide many cross-selling opportunities
-- the most compelling being promotion of Beckman Coulter's leading Immunoassay products to the loyal base of Olympus' chemistry customers.
Insmed to Host Second Quarter 2009 Conference Call
...ase, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities
for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to diff...
CuraGen Reports Second Quarter 2009 Financial Results
... that targets GPNMB. "We continue to be very positive about the development opportunities
for CR011 in breast cancer and melanoma," commented Dr. Timothy M. Shannon,...e proposed settlement of the shareholder class action lawsuits, development opportunities
for CR011 in breast cancer and melanoma and the expected timing for present...
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
... results from this study later this year and intends to explore partnership opportunities
as a potential path to continue the development of ANA773.
Reported ...tudy within the next several weeks; and (viii) plans to explore partnership opportunities
as a potential path to continue the development of ANA773. Such forward-lo...
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities
and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other ec...
NIST scientists study how to stack the deck for organic solar power
... the polymer. The electrical properties of the interface also change dramatically. The resultant structure gives the light-generated photocurrent more opportunities
to reach the proper electrodes and reduces the accumulation of fullerenes at the film bottom, both of which could improve the photovoltaic's efficienc...
BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
...g dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities
exist for the Company for products derived from the production of low-cost, biomass-derived sugars. For more information on Verenium, visit www.vereni...